創傷生物製剤市場：製品タイプ別、創傷タイプ別、エンドユーザー別-2025-2030年の世界予測

創傷生物製剤市場は、2023年に49億8,000万米ドルと評価され、2024年には54億3,000万米ドルに達すると予測され、CAGR 9.99％で成長し、2030年には97億米ドルに達すると予測されています。

創傷生物製剤は、成長因子、皮膚代替物、コラーゲンベースのマトリックスなどの製品を包含し、生物学的成分を活用することで治癒を促進・強化するように設計されています。これらの製品は、従来の治療に抵抗性を示すことが多い慢性・急性の創傷に対応するものであり、糖尿病患者や高齢者などの人々にとって不可欠なものです。病院、診療所、在宅医療の現場で広く応用されている創傷生物製剤は、早期回復を促し、感染リスクを最小限に抑えることで、患者のQOL向上に重要な役割を果たしています。市場力学は主に、慢性創傷患者の増加、技術の進歩、低侵襲処置への嗜好の高まりによって後押しされています。しかし、市場拡大の妨げとなっているのは、製品コストの高さ、規制要件の厳しさ、償還に関する課題です。特に新興国では、ヘルスケア支出の増加や先進的な創傷ケアソリューションに対する意識の高まりにより、大きな成長の可能性を秘めています。同市場はまた、生物製剤を個々の患者のニーズに合わせて調整できる個別化医療（パーソナライズド・メディシン）の分野でも機会を提供しており、製品開発におけるイノベーションが重視されています。バイオテクノロジー企業と研究機関の協力や提携は、画期的な治療法のさらなる進歩や市場投入までの時間短縮を促進します。とはいえ、企業は、競合の激しさや地域によって異なる規制状況などの制約を乗り越える必要があります。市場機会を活用するための戦略的推奨事項としては、費用対効果の高い生物製剤の研究開発への投資、様々な創傷タイプに対応するためによく研究された様々な生物製剤を含む製品ポートフォリオの多様化、未開拓市場への進出などが挙げられます。創傷生物製剤業界の性質は非常にダイナミックで、絶え間ないイノベーションと進化する患者の需要に後押しされています。

市場力学：急速に進化する創傷生物製剤市場の主要市場インサイトを公開

創傷生物製剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 創傷治療に関する政府の取り組み
  • 火傷や交通事故の増加
  • 世界の老人人口の増加
• 市場抑制要因
  • 創傷治療の高コスト
• 市場機会
  • 革新的な創傷治療用生物製剤のイントロダクション
  • 外科手術における生体工学的皮膚代替物の潜在的ニーズ
• 市場の課題
  • 訓練を受けた医師の不足と汚染に伴う合併症

ポーターの5つの力：創傷生物製剤市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：創傷生物製剤市場における外部からの影響の把握

外部マクロ環境要因は、創傷生物製剤市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析創傷生物製剤市場における競合情勢の把握

創傷生物製剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス創傷生物製剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、創傷生物製剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨創傷生物製剤市場における成功への道筋を描く

創傷生物製剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 創傷治療に関する政府の取り組み
    • 火傷や交通事故の発生率増加
    • 世界的に高齢化が進む
  • 抑制要因
    • 傷の治療費が高い
  • 機会
    • 革新的な創傷ケアバイオロジクスのイントロダクション
    • 手術におけるバイオエンジニアリングによる皮膚代替品の潜在的ニーズ
  • 課題
    • 訓練を受けた医師の不足と汚染に伴う合併症
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 創傷生物製剤市場：製品別

• 生物学的皮膚代替品
  • 無細胞動物由来製品
  • 生合成製品
  • ヒトドナー組織由来製品
• 外用剤

第7章 創傷生物製剤市場傷の種類別

• バーンズ
• 外科手術および外傷による創傷
• 潰瘍
  • 糖尿病性足潰瘍
  • 褥瘡
  • 静脈性潰瘍

第8章 創傷生物製剤市場：エンドユーザー別

• 外来手術センター
• 火傷センター
• 病院
• 創傷クリニック

第9章 南北アメリカの創傷生物製剤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の創傷生物製剤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの創傷生物製剤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Anika Therapeutics, Inc
• Avita Medical, Inc.
• B. Braun SE
• Bioventus Inc.
• Blaine Labs Inc.
• ConvaTec Group PLC
• Cytori Therapeutics Inc.
• Fibroheal Woundcare Pvt Ltd
• Integra Lifesciences Holdings Corporation
• Kerecis hf
• Marine Polymer Technologies, Inc.
• MediWound Ltd.
• Medline Industries, LP
• Merakris Therapeutics, Inc.
• MIMEDX GROUP, INC.
• Molnlycke Health Care AB
• Nuo Therapeutics, Inc.
• Organogenesis Inc.
• Polymedics Innovations GmbH
• Royal Biologics, Inc.
• Skye Biologics Holdings, LLC
• Smith & Nephew PLC
• Stability Biologics
• Stryker Corporation
• Surgilogix, LLC
• Tides Medical
• Vericel Corporation
• Viatris Inc.
• Vivex Biologics

LIST OF FIGURES

• FIGURE 1. WOUND BIOLOGICS MARKET RESEARCH PROCESS
• FIGURE 2. WOUND BIOLOGICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. WOUND BIOLOGICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. WOUND BIOLOGICS MARKET DYNAMICS
• TABLE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURNS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CANADA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. CHINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 72. CHINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 74. CHINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. INDIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 77. INDIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 79. INDIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. ITALY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 163. ITALY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 165. ITALY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. POLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 183. POLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 185. POLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. QATAR WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 188. QATAR WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 190. QATAR WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

The Wound Biologics Market was valued at USD 4.98 billion in 2023, expected to reach USD 5.43 billion in 2024, and is projected to grow at a CAGR of 9.99%, to USD 9.70 billion by 2030.

Wound biologics, encompassing products like growth factors, skin substitutes, and collagen-based matrices, are designed to expedite and enhance healing by leveraging biological components. These products are critical, as they address chronic and acute wounds that are often resistant to traditional treatments, making them essential for populations such as diabetics or the elderly. Widely applied in hospitals, clinics, and home healthcare settings, wound biologics hold a significant role in improving patients' quality of life by promoting faster recovery and minimizing infection risks. The market dynamics are primarily propelled by an increase in chronic wound cases, technological advancements, and the growing preference for minimally invasive procedures. However, market expansion is hampered by high product costs, stringent regulatory requirements, and reimbursement challenges. Notably, emerging economies present significant growth potential due to increasing healthcare expenditure and a rising awareness of advanced wound care solutions. The market also offers opportunities in personalized medicine, where biologics can be tailored to individual patient needs, emphasizing innovation in product development. Collaborations and partnerships between biotechnological firms and research institutions can drive further advancements and reduce time-to-market for breakthrough treatments. Nonetheless, companies need to navigate constraints such as competitive intensity and variable regulatory landscapes across different regions. Strategic recommendations for tapping into market opportunities include investing in R&D for cost-effective biologics, diversifying product portfolios to include a range of well-researched biologics catering to different wound types, and expanding into underpenetrated markets. The nature of the wound biologics industry is highly dynamic, driven by continuous innovation and evolving patient demands, highlighting the necessity for businesses to remain agile and responsive to technological and regulatory changes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wound Biologics Market

The Wound Biologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Government Initiatives Regarding Wound Care Treatment
  • Rising Incidences of Burn Injuries and Road Accidents
  • Increasing Geriatric Population Globally
• Market Restraints
  • High Cost of Wound Treatment
• Market Opportunities
  • Introduction of Innovative Wound Care Biologics
  • Potential Need for Bioengineered Skin Substitutes in Surgeries
• Market Challenges
  • Lack of Trained Physicians and Complications Associated with the Contamination

Porter's Five Forces: A Strategic Tool for Navigating the Wound Biologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wound Biologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wound Biologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wound Biologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wound Biologics Market

A detailed market share analysis in the Wound Biologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wound Biologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wound Biologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wound Biologics Market

A strategic analysis of the Wound Biologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wound Biologics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Anika Therapeutics, Inc, Avita Medical, Inc., B. Braun SE, Bioventus Inc., Blaine Labs Inc., ConvaTec Group PLC, Cytori Therapeutics Inc., Fibroheal Woundcare Pvt Ltd, Integra Lifesciences Holdings Corporation, Kerecis hf, Marine Polymer Technologies, Inc., MediWound Ltd., Medline Industries, LP, Merakris Therapeutics, Inc., MIMEDX GROUP, INC., Molnlycke Health Care AB, Nuo Therapeutics, Inc., Organogenesis Inc., Polymedics Innovations GmbH, Royal Biologics, Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stability Biologics, Stryker Corporation, Surgilogix, LLC, Tides Medical, Vericel Corporation, Viatris Inc., and Vivex Biologics.

Market Segmentation & Coverage

This research report categorizes the Wound Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biologic Skin Substitutes and Topical Agents. The Biologic Skin Substitutes is further studied across Acellular Animal-derived Products, Biosynthetic Products, and Human Donor Tissue-derived Products.
• Based on Wound Type, market is studied across Burns, Surgical and Traumatic Wounds, and Ulcers. The Ulcers is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Ulcers.
• Based on End-User, market is studied across Ambulatory Surgery Centers, Burn Centers, Hospitals, and Wound Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Government Initiatives Regarding Wound Care Treatment
    • 5.1.1.2. Rising Incidences of Burn Injuries and Road Accidents
    • 5.1.1.3. Increasing Geriatric Population Globally
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of Wound Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of Innovative Wound Care Biologics
    • 5.1.3.2. Potential Need for Bioengineered Skin Substitutes in Surgeries
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of Trained Physicians and Complications Associated with the Contamination
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Wound Biologics Market, by Product

• 6.1. Introduction
• 6.2. Biologic Skin Substitutes
  • 6.2.1. Acellular Animal-derived Products
  • 6.2.2. Biosynthetic Products
  • 6.2.3. Human Donor Tissue-derived Products
• 6.3. Topical Agents

7. Wound Biologics Market, by Wound Type

• 7.1. Introduction
• 7.2. Burns
• 7.3. Surgical and Traumatic Wounds
• 7.4. Ulcers
  • 7.4.1. Diabetic Foot Ulcers
  • 7.4.2. Pressure Ulcers
  • 7.4.3. Venous Ulcers

8. Wound Biologics Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Burn Centers
• 8.4. Hospitals
• 8.5. Wound Clinics

9. Americas Wound Biologics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Wound Biologics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Wound Biologics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Anika Therapeutics, Inc
• 3. Avita Medical, Inc.
• 4. B. Braun SE
• 5. Bioventus Inc.
• 6. Blaine Labs Inc.
• 7. ConvaTec Group PLC
• 8. Cytori Therapeutics Inc.
• 9. Fibroheal Woundcare Pvt Ltd
• 10. Integra Lifesciences Holdings Corporation
• 11. Kerecis hf
• 12. Marine Polymer Technologies, Inc.
• 13. MediWound Ltd.
• 14. Medline Industries, LP
• 15. Merakris Therapeutics, Inc.
• 16. MIMEDX GROUP, INC.
• 17. Molnlycke Health Care AB
• 18. Nuo Therapeutics, Inc.
• 19. Organogenesis Inc.
• 20. Polymedics Innovations GmbH
• 21. Royal Biologics, Inc.
• 22. Skye Biologics Holdings, LLC
• 23. Smith & Nephew PLC
• 24. Stability Biologics
• 25. Stryker Corporation
• 26. Surgilogix, LLC
• 27. Tides Medical
• 28. Vericel Corporation
• 29. Viatris Inc.
• 30. Vivex Biologics